The mammalian non-histone "high mobility group" A (HMGA) proteins are the primary nuclear proteins that bind to the minor groove of AT-rich DNA. They may, therefore, influence the formation and/or repair of DNA lesions that occur in AT-rich DNA, such as cylobutane pyrimidine dimers (CPDs) induced by UV radiation. Employing both stably transfected lines of human MCF7 cells containing tetracycline-regulated HMGA1 transgenes and primary Hs578T tumor cells which naturally over-express HMGA1 proteins, we show that cells over-expressing HMGA1a protein exhibit increased UV sensitivity. Moreover, we demonstrate that knockdown of intracellular HMGA1 concentrations via two independent methods abrogates this sensitivity. Most significantly, we observe that HMGA1a overexpression inhibits global genomic nucleotide excision repair (NER) of UV-induced CPD lesions in MCF-7 cells. Consistent with these findings in intact cells, DNA repair experiments employing Xenopus oocyte nuclear extracts and lesion-containing DNA substrates demonstrate that binding of HMGA1a markedly inhibits removal of CPDs in vitro. Furthermore, UV 'photo-footprinting' demonstrates that CPD formation within a long run of Ts (T 18 -tract) in a DNA substrate changes significantly when HMGA1 is bound prior to UV irradiation. Together, these results suggest that HMGA1 directly influences both the formation and repair of UV-induced DNA lesions in intact cells. These findings have important implications for the role that HMGA protein overexpression might play in the accumulation of mutations and genomic instabilities associated with many types of human cancers.
In most organisms, DNA helix distorting bulky lesions are repaired by NER involving the excision and replacement of 24-32 nts of the damaged DNA strand (1) . Many factors, such as (a) the type of DNA damage, (b) the DNA sequence surrounding the lesion, (c) the position in chromatin and (d) the interactions with DNA binding proteins, are known to affect the efficiency of NER (2) (3) (4) . For instance, inhibitory effects of nucleosomes on NER have been observed in vitro and in intact cells (5-9), presumably reflecting the limited access of NER proteins to these lesions (10) . In a similar way, certain DNA binding proteins, such as transcription factor IIIA and HMGB1 proteins are known to repress NER at their cognate sequences (11) (12) (13) . Conversely, transcriptional activators and the RNA polymerase II elongation complex are associated with enhanced repair of transcribing genes (14, 15) . Furthermore, in contrast to HMGB1, another member of the HMG protein superfamily that specifically binds to nucleosomes, HMGN1, has been shown to, likewise, enhance NER of UV-damaged DNA in vivo (16) .
Stable DNA photoproducts produced by UVinduced covalent linkage between adjacent bases are prototypes of helical distorting, bulky lesions (17) . Among a variety of possible UV-induced photoproducts, CPDs are the most abundant, stable forms (17) and, if unrepaired, are known to cause mutations and skin cancer (2, 18) . CPDs alter DNA structure from normal B-form, causing severe bending of the helical axis and disruption of Watson-Crick base pairs at the lesion sites (19) . Additionally, these lesion-induced distortions can obstruct progression of both RNA and DNA polymerases (20, 21) . Besides direct blockage of polymerases, however, UV photoproducts can inhibit transcription by competing with normal promoters for transcription factors (22) or possibly by interrupting formation of the transcription initiation complex (23, 24) .
The HMGA proteins are a family of nonhistone chromosomal proteins that mediate a variety of biological functions, including regulation of gene transcription, modulation of chromatin structure, and induction of neoplastic transformation and metastatic progression (reviewed in 25). HMGA1a, HMGA1b (alternatively spliced forms of the HMGA1 proteins) and HMGA2 are principal members of the family and share distinct structural properties, such as three separate DNA-binding domains (called 'AT-hooks') and an acidic C-terminal domain (25) . The HMGA proteins bind to nucleosomes (26) , four way junctions (27) , supercoiled DNA (28), and the minor groove of AT-rich sequences (29) . Interestingly, the structure of DNA (rather than its sequence) is thought to be important for 2 HMGA binding. HMGA binding also induces changes in DNA structure which, in the case of gene transcriptional activation, leads to formation of multi-nucleoprotein complexes called "enhanceosomes" (30) in the gene's regulatory promoter elements. Finally, HMGA1a is a proto-oncogene (31) that is over-expressed in a large number of different naturally occurring cancers (25) and whose experimental up-regulation induces metastatic progression and increased malignancy of neoplastic cells (32) .
Consideration of these characteristics of CPDs and HMGA proteins led us to suspect that these proteins might participate in the process of DNA repair or DNA damage formation at AT-rich sequences. To investigate this possibility, we examined the consequences of HMGA1 over-expression and DNA binding on the repair of CPD lesions in intact cells and in vitro, respectively. The UV sensitivity and efficiency of global genomic repair was investigated in transgenic human breast adenocarcinoma cell lines containing an inducible HMGA1 gene. The results of these studies demonstrated that HMGA1 over-expression in human cells inhibits their ability to survive exposure to UV light and significantly reduces their efficiency of global genomic nucleotide excision repair.
To further investigate the possible mechanism(s) involved in HMGA1 inhibition of NER in intact cells, in vitro repair experiments were also performed. A complex of the HMGA1 protein with the PRRII region of the IL-2Rα gene promoter (33) was employed as a model for studying the effects of these proteins on both DNA damage and repair in a cell free system. The results of these in vitro studies demonstrated that UV photoproducts do not markedly affect HMGA1 binding to lesion-containing DNA. Nevertheless, HMGA1 binding does change the CPD yield spectrum in a poly (dT) sequence (or T 18 -tract) of the PRRII fragment, suggesting that HMGA1 binding perturbs the DNA structure of the T 18 -tract, which leads to altered CPD formation. Most importantly, and in agreement with the results in living cells, we found that repair of CPDs in the PRRII DNA-HMGA complex by Xenopus oocyte nuclear extracts is strongly inhibited by HMGA1 binding. Taken together, these findings suggest that inhibition of DNA repair processes by HMGA proteins may contribute to the genetic and chromosomal instabilities commonly found in cancerous cells which, almost universally, over-express these proteins.
MATERIALS AND METHODS
Cell culture and cell cycle distribution analysis. The human breast adenocarcinoma cell line MCF7-tet (i.e., MCF7/Tet-OFF) (BD Biosciences) was maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 10 mM HEPES, 100 U/ml penicillin G sodium, 100 µg/ml streptomycin sulfate, and 100 µg/ml G418 (Research Products International). Clonal cell line MCF7-7C-Cs is a derivative of MCF7/Tet-OFF cells that has been stably transfected with a tetracycline-regulated pTRE vector encoding HA-tagged HMGA1a cDNA (32) . This stably transfected line was maintained in the presence of 100 µg/ml of hygromycin. The MCF7-7C-Cs cell line expresses high levels of transgenic HA-tagged HMGA1a protein when grown in medium lacking tetracycline (these are referred to as 'ON' cells). To prevent expression of the HA-tagged HMGA1 transgenes, the MCF7-7C-Cs cells were cultured in medium containing 2 µg/ml tetracycline (and are referred to as 'OFF' cells). The Hs578T line of human mammary carcinoma cells (ATCC Number; HTB-126; American Type Culture Collection, Manassas, VA) was cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 2mM L-glutamine. Prior to all experiments the levels of endogenous and transgenic HA-tagged HMGA1 proteins in test plate cell cultures were determined by Western blot analysis of cell extracts prepared with TRIzol (Life Technologies), using either a monoclonal antibody against the HA-tag of transgenic proteins (32) or a specific polyclonal antibody against HMGA1 proteins (37). Western blots reacted with a polyclonal HRP-conjugated anti-actin rabbit antibody (Sigma, Co.) served as loading controls. Once over-expression of HMGA1 protein was confirmed in test plates, parallel experimental cell cultures were harvested and fixed in cold absolute ethanol. Cells were then stained with 0.01 mg/mL propidium iodide (PI) for DNA content analysis by flow cytometry using a Becton Dickinson FACS caliber Cytometer and cell Quest Software.
trypsin/EDTA to remove monolayers, followed by centrifugation. Cell pellets were then resuspended in limited volumes of growth media and diluted 1:1 in 100 µl of 0.4% Trypan Blue dye. After 5 min, 20 µl of cell suspension was loaded onto a Levy Ultra Plane hemacytometer and the number of viable cells determined.
Percent survival was calculated by comparison to non-UV-irradiated controls.
To evaluate the ability of cells to proliferate after UV exposure, approximately 2.5 x 10 5 transgenic MCF-7 cells were plated in 100-mm cell culture dishes containing Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM Lglutamine, 10 mM HEPES, 100 U/ml penicillin G sodium, 100 µg/ml streptomycin sulfate, and 100 µg/ml G418. Cells in the exponential growth phase were then either irradiated at one of several UV doses (2, 10, 25, 50 or 100 J/m 2 ) or left unirradiated (control). Following irradiation, cells were harvested and re-plated in the appropriate medium at a concentration of 1000 cells per 100-mm dish. After 10 days, colonies were stained with crystal violet (0.1% in 95% ethanol) and scored using a light microscope. Colony counts in UV treated samples were compared to number of colonies formed in non-UV-irradiated plates to determine percent of colony formation.
RNAi-mediated HMGA1 knockdown analyses. All cell cultures were maintained as described above for survival determination. Once cells reached 50% confluence, media was replaced with antibiotic free medium for 24 hours. Cells were then transfected with 20nM siRNA targeting the HMGA1 gene (Santa Cruz Biotechnology) using Lipofectamine 2000 ® (Invitrogen) according to the manufacturer's instructions. 48 hours post-transfection, cells were assayed for HMGA1 protein levels via Western blotting and survival analyses after UV exposure were repeated following the protocol described above. Again, percent survival was calculated by comparison to non-UV-irradiated controls.
Global Genomic Repair of CPD Lesions in Living
Cells. Both MCF-7-tet ('OFF') and MCF7-7C-Cs ('ON') cells were cultured as described above. Once cells reached confluence, as determined by light microscopy, 2 mM hydroxyurea (HU) was added to each plate for 1 hr to suppress and residual cell cycle progression. After HU treatment, media was removed and cells were irradiated at 10 J/m 2 . Media was then replaced and cells were incubated under standard conditions described above (see survival determination methods) for various times post irradiation to allow repair to occur. At the desired time post irradiation, genomic DNA was isolated from the cells by published methods (38) . Briefly, cells on each plate were resuspended in 1 ml of 0.3 M sucrose, 60 mM KCl, 15 mM NaCl, , 0.5 mM spermidine, 0.15 mM spermine, 2 mM EDTA, 0.1% NP-40, and 60 mM Tris-HCl (pH 8.0). Then, the mixture was transferred into a microcentrifuge tube, and incubated on ice for 5 min. Nuclei were pelleted by centrifugation at 1000 g for 5 min, washed once with the buffer (without NP-40), and resuspended in 1.5 ml of 150 mM NaCl and 5 mM EDTA (pH 8.0). The nuclei were incubated with proteinase K (final concentration: 0.3 mg/ml) at 37ºC for 1 hr, after which 0.15 mg DNase-free RNase A was added and incubation continued for an additional 30 min. The DNA was isolated by phenol extraction and ethanol precipitation.
The DNA samples (5 μg) were cleaved at CPDs using T4 endonuclease V (T4 endo V), as described above, and ~5 μg of DNA per sample were separated on 1% alkaline agarose gels at 20 V for 20 hr. DNA was depurinated (0.25 N HCl for 30 min) and transferred to nylon membranes in 0.4 N NaOH. Radioactive probes were generated from EcoRI-digested MCF-7 cell genomic DNA followed by random priming (RadPrime™, Invitrogen). Quantification of CPDs was performed on data from phosphorimages of the Southern blots of these gels, using ImageQuant software and number-average DNA length analysis (39) .
Preparation of the IL-2Rα gene promoter PRRII DNA fragment. Standard PCR was performed with Taq polymerase to amplify a 213 bp DNA fragment (-153 to +60, +1 denotes the transcription start site of IL-2Rα) using a plasmid containing the PRRII (-472 to +109) of the human IL-2Rα gene as a template (34) . The PCR primer pair sequences were 5'-CCTGGTTTGAAAAATTACCGC (-153 to -133) and 5'-ATGTGGGATGGGAAGAATCG (+60 to +42). After 30 cycles of PCR, the products were extracted with PCI (phenol/chloroform/isoamyl alcohol, 25:24:1), and then ethanol precipitated. The DNA was dissolved in TE buffer (10 mM Tris, pH 7.5, 1 mM EDTA), quantified by absorbance at 260 nm and stored at -20°C. For HMGA1 binding assays, DNA was end-labeled with T4 polynucleotide kinase and [γ-
32 P]ATP. To obtain a single end-labeled DNA fragment, the 5' end of a primer (+60 to +42) was labeled with 32 P by T4 polynucleotide kinase and used for the PCR step. In order to introduce UV photoproducts, 10 μl of DNA (or HMGA1-DNA complex) solution was irradiated under a bank of lowpressure Hg UV lamps (primarily 254 nm) and the UV dose was measured with a Spectroline DM-254N short wave UV meter (Spectronic Corp.).
Electrophoretic mobility shift assays (EMSA) of HMGA1-DNA complexes.
Recombinant human HMGA1a protein (referred to as HMGA1 for simplicity in this report) was produced from E. coli strain BL21(DE3)pLysS carrying pET7C-hHMG-I (34). The isolated 213 bp PRRII DNA fragment was incubated with increasing amounts of HMGA1 in 18 μl of binding buffer (17 mM Tris, pH 7.8, 41 mM NaCl, 1.7 mM EDTA, 333 ng/ml poly (dG . dC), and 67 μg/ml bovine serum albumin). After incubation for 30 min at room temperature, the solution was mixed with 2 μl of 10 × loading buffer (25% glycerol, 100 mM EDTA, 1 mg/ml bromphenol blue, 1 mg/ml xylene cyanol), loaded onto a 6.5% polyacrylamide gel in 0.25 × TBE buffer, and electrophoresed in 0.25 × TBE at 17 V/cm for 2 hr at room temperature. Subsequently, the gel was vacuumdried and exposed to a PhosphorImager screen (Amersham Bioscience) and visualized with a PhosphorImager (Amersham Bioscience Model 445-0P90).
CPD formation in HMGA1-DNA complexes. Samples containing approximately 0.56 pmol of DNA (estimated from the concentration of PCR primers) and various amounts of HMGA1 were mixed in 56 μl of HMGA1 binding buffer as described above. The mixtures were irradiated with various doses of (primarily) 254 nm UV light (0 to 2000 J/m
2 ), and 6 μl aliquots of the mixtures were loaded onto a 6.5% native gel for EMSA. The remaining sample for each UV dose was used for CPD mapping as described below. The 20 μl aliquots of the binding mixture were mixed with 20 μl of repair buffer (10 mM HEPES, pH 7.4, 3 mM dithiothreitol, 0.25 mM dNTP, 70 mM KCl, 7 mM MgCl 2 , 0.1 mM EDTA, 10% glycerol and 1% polyvinylpyrrolidone) and 3.2 μl of Xenopus oocyte nuclear extracts (provided by Dr. E. Ackerman, Pacific Northwest National Laboratory, Richland, WA), followed by incubation at room temperature for various times (35) . The DNA was isolated and treated with T4 endo V to specifically cleave DNA near CPD lesions, and the resulting DNA fragments were fractionated on a 7 M urea, 6% acrylamide gel as described below.
In vitro repair of
CPD mapping and UV Photofootprinting. DNA was isolated from each sample using PCI extraction and ethanol precipitation. After drying the pellet, the DNA was resuspended in 9 μl of T4 endo V reaction buffer (100 mM Tris, pH 7.4, 100 mM NaCl, 100 μg/ml bovine serum albumin, and 10 mM EDTA). About 8 ng of T4 endo V was added to the solution and incubated at 37°C for 2 hr. The resulting DNA fragments were fractionated by electrophoresis on a 6% polyacrylamide sequencing gel (20 × 60 cm) with 1 × TBE at 60 W for 4 hr, and visualized on a Phosphorimager, as described earlier.
Intensities in CPD bands were measured using ImageQuant NT software (Amersham Biosciences). Loading differences were corrected by normalizing the intensity of each band to the sum of all band intensities in a lane. Thus, the value of each band was expressed as the percentage of the total intensity of a lane. The average CPDs per strand was obtained from the intensity of the intact fragment (i.e., P o ), assuming a Poisson distribution of UV damaged fragments, as described previously (36) .
RESULTS

Over-expression of HMGA1 Proteins Inhibits NER in MCF7 Cells
Mammalian cells that are deficient in various aspects of DNA repair exhibit, in most cases, increased sensitivity to DNA-damaging agents (43) . To gain insight into whether or not the HMGA1 proteins play a role in NER of UV-induced CPD lesions in vivo, the UV sensitivity of genetically engineered human cell lines was examined by two methods, colony forming ability and dye exclusion after UV exposure. For these studies, human MCF7 mammary epithelial cell lines were used that contain stably integrated, tetracycline-regulated transgenes coding for either the HMGA1a or HMGA1b isoform proteins (32) . The endogenous levels of nontransgenic HMGA1 proteins in these MCF7 cells are very low (32) . Induction of transcriptional expression of the HMGA1 transgenes is controlled by addition of varying amounts of tetracycline to the cell culture medium. Western blot analysis has demonstrated that within 10 days of inducing the cells to express the transgenic protein the intracellular concentration of HMGA1a is greatly increased (>10-fold) in the HMGA1a 'ON' cells, compared to the concentration in HMGA1a 'OFF' cells (data not shown). Quantitative assessments have also demonstrated that, after longer periods of induction, the amount of transgenic HMGA1a protein in the 'ON' cells can reach up to ~40-fold higher than in the 'OFF' cells (44) . It should be emphasized that the range observed in many naturally occurring human tumors is between 15 to >50-fold more than normal cells (60) and thus the data presented here represents effects seen within the physiological range of HMGA1 protein over-expression found in various cancer cells.
The viability of cell lines was monitored by the colony forming assay after exposure to various doses of UV radiation and the % colony forming ability determined from the non-irradiated colonies as controls ( Figure 1A) . At UV doses from 2 J/m 2 to 100 J/m 2 , MCF7 cells over-expressing HMGA1a proteins were less capable of forming viable colonies (50 cells or more) when compared to MCF7 cells not over-expressing these proteins (i.e. 'OFF' cells). The greatest differences in viability occurred at UV doses of 10 and 25 J/m 2 , which induce the physiological dose equivalent of CPDs observed in human cells after only a few minutes exposure to solar UVB on a bright summer day (e.g., see 17 and references therein).
Given previous data demonstrating induction of cell cycle progression by HMGA1 proteins (44) , flow cytometric analysis was employed to determine if cell cycle distributions between the two cell lines were different ( Figure 1B) . No significant differences in the number of gated cells at each cell cycle stage were observed, indicating that while HMGA1 over-expressing cells do exhibit a faster doubling time, the cell cycle distribution of 'ON' cells in a random population is the same as that of 'OFF' MCF7 cells containing only very low levels of endogenous HMGA1 proteins.
To further investigate UV sensitivity in these cell lines, a trypan blue dye exclusion assay was employed to monitor cell viability (Figure 2A) . With this assay, cells are not required to attach to culture dishes and traverse the cell cycle as in colony forming assays, but are simply required to survive a UV exposure (as assessed by exclusion of the dye). Similar to the colony forming assay, cells were cultured to induce expression of the HMGA1 gene and then irradiated at different doses of UV (2-100 J/m 2 ). After UV irradiation, cells were given 96 hours to 'recover' before survival was measured and compared to non-irradiated cells as a control. At all UV doses examined, cells expressing transgenic HMGA1a displayed decreased survival after UV exposure ( Figure  2A) . Indeed, between doses of 10 and 100 J/m 2 , 'ON' cells were as much as 50% more sensitive to UV damage compared to 'OFF' cells.
Furthermore, survival of transgenic 'OFF' cells was the same as for the nontransgenic parental MCF7 cells (data not shown). These results indicate that MCF7 cells over-expressing HMGA1 proteins exhibit a phenotype characteristic of mammalian cells (partially) deficient in NER of CPD lesions (43) . Additionally, to investigate the generality of these results, this same experiment was repeated using a primary human carcinoma cell line, Hs578T, that naturally expresses high levels of endogenous HMGA1 proteins (32) , and these cells also exhibit increased sensitivity to UV exposure (Figure 2A) . It is important to note that, while considered a less stringent estimate of cell viability, the UV sensitivity of HMGA1-expressing cells determined by trypan blue exclusion was similar to that observed using the colony forming assay.
To determine if knockdown of HMGA1 proteins in over-expressing cells could reverse the UV sensitivity effects observed, both an RNAi-based approach as well as a tetracycline depletion approach were employed (Figures 2B and 2C ). Hs578T cells were transfected with 20 nM siRNAs targeting the HMGA1 transcript and cell survival after UV irradiation was again monitored. Western blot analysis after transfection revealed a 2.5-fold decrease in the concentration of HMGA1a protein in these cells (data not shown). Importantly, this relatively modest decrease in the amount of intracellular HMGA1a in over-expressing Hs578T cells nevertheless resulted in a significant increase in their ability to survive moderate dose UV exposures ( Figure 2B ).
To verify survival results obtained in Hs578T cells using RNAi-mediated knockdown of HMGA1, a tetracycline depletion approach was used as an independent means of knocking down HMGA1 levels in transgenic cells ( Figure 2C ). In this set of experiments, transgenic MCF7 cells were cultured in the presence of 2.5ug/mL tetracycline to suppress HMGA1 expression. As a control, normal MCF7 cells were also cultured in the presence of tetracycline. Ten days post tetracycline treatment, when Western blot analysis demonstrated a complete depletion of HA-tagged HMGA1 proteins from the transgenic cells (data not shown), cell survival after UV irradiation was again monitored. The UV survival of transgenic MCF7 cells (after knockdown) was equivalent to survival of normal MCF7 cells (Figure 2C) , and no significant effects from adding tetracycline to the culture media were observed in control cells.
The ability of the 'OFF' and 'ON' cell lines to repair UV-induced CPDs was directly examined by adapting a sensitive, quantitative method developed for measuring the efficiency of global genomic DNA repair in yeast (39) for use with human MCF7 cells. In this assay, a CPD-specific endonuclease (T4 endo V) that makes single-strand cuts at CPD sites (40) is employed to monitor strand breaks remaining in genomic DNA as a function of repair time. As shown by the representative blots in Figure 3A for 'OFF' and 'ON' cells (upper and lower panels, respectively), at each time point genomic DNA is isolated from cells and treated (+) or not treated (-) with T4 endo V, separated on denaturing agarose gels and transferred to a nitrocellulose membrane by a standard southern blot protocol. Random hybridization probes are then used to detect all genomic DNA sequences with minimal sequence bias. Analysis of scans of the phosphorimage signal profiles of the heterogeneous populations of DNA fragments on the membrane can be integrated to determine the numberaverage size of DNA fragments in each lane (39) . As illustrated in Figure 3A , genomic DNA isolated from cells immediately after UV irradiation (0 hr repair) and digested with T4 endo V (+ lane) migrates as a smear of heterogeneous single stranded fragments whose ensemble average size [indicated by an asterisk (*)] can be accurately determined ((39) and references therein). This is in contrast to the DNA not treated with T4 endo V, which migrates only a short distance into the gel ( Figure 3A , 0 hr T4 endo V (-) lanes). Importantly, at various times following irradiation, when the cells undergo global genomic repair, the number average size of T4 endo V digested DNA fragments increases as a consequence of the removal of CPD lesions ( Figure 3A , compare + T4 endo V lanes). Moreover, repair is nearly complete by 24 hr post-irradiation and the DNA fragments approach the migration of undamaged DNA near the top of the blot (Figure 3A , compare the dashed lines connecting the asterisks to the UV-lanes).
The representative scans of gel lanes (0 hr and 3 hr post-irradiation) show that the rate of NER removal of CPD lesions from genomic DNA is significantly retarded in the 'ON' cells over-expressing HMGA1 protein ( Figure 3B) . In fact, differences in repair capacities between 'ON' and 'OFF' cells were evident at all time points examined ( Figure 3C) . The difference in repair capacities, however, is most obvious at 3 hr post UV exposure (Figures 3B & 3C) , where 'OFF' cells have repaired approximately 66% of induced CPDs, while 'ON' cells have repaired < 5% of these lesions. Furthermore, in contrast to the in vitro repair results (see Figure 6 , below), the observed difference in repair completion at 24 hr (~17%) remains for at least 96 hr post UV exposure, reaching the limit of repair detection by this method (unpublished data). In addition, based on the average number of CPDs per kb calculated at time 0 hr by this method (0.95 ± 0.17 for 'OFF' cells and 0.91 ± 0.20 for 'ON' cells), there is no indication that overexpression of HMGA1 proteins alters the amount of DNA damage induced by this UV dose (10 J/m 2 ). This was also shown by immunocytochemical analyses employing a CPD-specific antibody, wherein there were no statistically significant differences in the average fluorescence intensity of HMGA1 'OFF' and 'ON' cell nuclei immediately after a 10 J/m 2 dose of UV radiation (unpublished results). These data provide the first evidence linking over-expression of HMGA1 proteins with compromised repair efficiency in the chromatin of living cells.
HMGA1 Protein Inhibits NER of CPD Lesions in vitro
A systematic investigation was also undertaken to determine if HMGA1 proteins influence either the formation or repair of CPD lesions in vitro. The AT-rich sequences of the PRRII region of the human IL-2Rα gene promoter were used for these studies ( Figure 4A) . Our previous footprinting analyses (33, 34) have demonstrated that this region contains at least three major HMGA1 protein binding sites within a 50 bp sequence ( Figure 4A ). EMSAs were performed with increasing amounts of HMGA1, ranging from 0.5 to 16-fold ratios of protein to DNA, and constant DNA concentration. As shown in Figure 4B , with increasing protein concentration a series of bands appeared corresponding to the multiple binding sites for HMGA1 molecules to the PRRII fragment. Several (more than 5) discrete bands were identified at moderately high (~ 8-fold of DNA) concentrations of HMGA1. The discrete bands presumably reflect HMGA1 binding to the three AT-rich sequences (shown in Figure 4A ) and additional AT-rich sites, such as AAAAATTA (-144 to -137) and TTAAA (-27 to -23) in the DNA fragment. In addition, migration of DNA is increasingly retarded at a higher concentration (16-fold of DNA) of HMGA1 ( Figure  4B ), due to additional binding of HMGA1 into nonspecific complexes (37).
Similarly, EMSAs were performed with various amounts of HMGA1 and DNA irradiated with 0, 200 or 400 J/m 2 UV light prior to protein binding ( Figure 4C) . The concentrations of DNA (0.05 pmol) and HMGA1 (0 to 0.1 pmol) were empirically chosen to obtain an appropriate range of DNA migration. As shown in Figure 4C , no significant difference was observed in retardation of DNA migration between no UV (-UV) and exposure to 200 or 400 J/m 2 of UV light. Assuming that CPD formation within the fragment population follows a Poisson distribution (36), the average CPD yield is 0.8 CPDs per labeled strand at 400 J/m 2 ( Figure 5B , lanes 5 and 6). Therefore, up to almost one CPD/strand (and 2 CPDs/dsDNA fragment), the level of UV photoproducts doesn't have a noticeable effect on HMGA1 binding. In addition, using DNaseI footprinting, we observed that HMGA1 binding also protects both the ATATAA (-128 to -123) and ATATAAA (-89 to -83) sequences of the UV-irradiated DNA, indicating HMGA1 interacts preferentially with AT-rich regions of the DNA (data not shown).
CPD formation in the pre-formed complex of HMGA1 and the PRRII fragment was also examined. Initially, the 'stability' of the complex after different UV doses was tested using EMSA. Prior to UV irradiation, 5' end-labeled DNA and various amounts of HMGA1 were mixed to form complexes (-UV lanes in Figure  5A) .
The complexes were then irradiated with increasing doses of UV light. As shown in Figure 5A , UV doses of 400 to 2000 J/m 2 , which produce ~ 2 to 4 CPDs/PRRII fragment, respectively, do not induce an obvious dissociation of the complexes.
The formation of CPDs in each sample was analyzed by T4 endo V digestion followed by denaturing gel electrophoresis (41) . The CPD yields at specific sites in a given strand are directly proportional to the intensities of the corresponding bands on a denaturing gel. The T 18 -tract (-116 to -98) and CT-rich region (-83 to -67) exhibit multiple bands representing CPDs at each dipyrimidine site ( Figure 5B) . Interestingly, CPD yields are unevenly distributed along the T 18 -tracts of free DNA ( Figure 5B, lanes 6, 14 and 22) . Scans of the T 18 -tracts show that CPD yields at 400 J/m 2 are maximal at the 2 nd or 3 rd CPD from the 3' end ( Figure 5C , black scan). This preferential CPD formation most likely reflects the unusual DNA structure in poly (dT) sequences (42) . However, as seen in Figure 5C (gray scan), UV irradiation of the HMGA1 complexes increases the CPD yield at most sites in the T 18 -tract. Moreover, the complex shows a different CPD pattern from free DNA, with three separate CPD maxima near the 4 th , 12 th and 16 th TT pairs from the 3' end of the T 18 -tract ( Figure 5C , gray scan). This modulation of CPD formation is dependent on the concentration of HMGA1, being more pronounced at the 5 nM HMGA1 concentration than at the 1 nM concentration (e.g., compare lanes 8 and 12 in Figure 5B ). In addition, similar patterns were observed at UV doses of 1 kJ/m 2 and 2 kJ/m 2 (compare lanes 16 and 20 and lanes 24 and 26, respectively, in Figure 5B ).
The DNA repair activity of Xenopus oocyte nuclear extracts was examined in the HMGA1-DNA complex as described previously for repair of the TFIIIA-5S ribosomal RNA gene complex (11) . First, radiolabeled DNA was irradiated at 400 J/m 2 to generate UV photoproducts at dipyrimidine sites, and incubated with an excess of HMGA1 to saturate most of the ATrich sequences in the fragments. The HMGA1-DNA mixture and free DNA samples were then incubated with Xenopus oocyte nuclear extracts for various times. In a separate experiment, aliquots from the samples taken following the different repair times were examined by native gel electrophoresis. The results indicate that the majority of PRRII DNA in the presence of HMGA1 exists as the HMGA1-DNA complex throughout the repair reaction (unpublished results).
The CPD distribution in each sample was identified by T4 endo V digestion followed by denaturing gel electrophoresis and repair is observed by the disappearance of bands ( Figure  6A) . As can be seen, most CPDs are efficiently removed from the DNA within 30 min in the absence of HMGA1 (compare lanes 2 and 4 in Figure 6A ). However, removal of CPDs in the HMGA1 complex is significantly slower (Figure 6A, lanes 3, 5, 7) , taking 1.5 hr for nearly complete repair at most sites.
Quantification of the group of CPD bands in the T 18 track (nts -116 to -97) of the PRRII element was performed by integrating the intensity inside this region of the sequencing gel.
These values were then normalized to the total signal in each lane to adjust for variations in loading. Differences in the repair of free and complexed DNA are clearly observable in the T 18 -tract (Figure 6B) , demonstrating that HMGA1 binding significantly impedes repair of CPDs in vitro. Decreased repair also occurs at CPDs in another AT-rich sequence of the DNA fragment (e.g., see broad band of multiple CPD sites marked by a closed circle in Figure  6A ). Additionally, a smaller, but significant decrease in repair is also observed in adjacent regions just outside of the AT-hook binding sites of HMGA1 (Figure 6A ).
DISCUSSION
In this study, we demonstrate that a transgenic line of human MCF7 cells, as well as a primary human tumor cell line (Hs578T), over-expressing HMGA1 proteins exhibit an increase in UV sensitivity and a decrease in cell viability, phenotypes characteristic of cells deficient in NER. Over-expression of even relatively low levels of HMGA1 proteins in these cells increases their sensitivity to UV-induced killing (Figures 1 and 2) . Moreover, removal of CPDs from total genomic DNA of the MCF7 cells over-expressing transgenic HMGA1 is significantly repressed (Figure 3) . Together, these results demonstrate for the first time that over-expression of HMGA1 proteins in cells inhibits repair of UV-induced DNA lesions in intact cells.
To investigate the possible molecular mechanisms responsible for this repair deficiency, we examined the binding and repair of HMGA1-DNA complexes in vitro, using a DNA fragment containing the positive regulatory region II of the IL-2Rα gene ( Figure 4A) . Our EMSA results indicate that UV photoproducts per se do not enhance nor significantly decrease HMGA1 binding (Figure 4B) . In addition, we have performed EMSAs with HMGA1 and a DNA oligonucleotide containing a chemically synthesized cyclobutane thymine dimer (CTD). The EMSA of the damaged DNA was almost identical to that of undamaged DNA (data not shown), suggesting that HMGA1 had no preferential binding affinity for the CTD in that sequence. The structural requirement for high affinity binding of HMGA1 can be deduced from the manner in which the DNA-binding domains of the protein, the AT-hook motifs, interact with the minor groove of AT-rich substrates (47) . The structural hallmark of AT-rich DNA that is recognized by HMGA1 proteins is a narrow minor groove, where alternating dAdT, poly (dT) and dAdAdTdT sequences produce minor grooves that are almost 2 Å narrower than that of B-DNA (48) .
In contrast, DNA containing a cyclobutane thymine dimer is bent by ~30 o and, compared to B-form DNA, the CPD lesion itself exhibits an extreme widening of both minor and major groves and has a severe change in base pairing geometry on its 5' side (19) . Such structural differences in DNA might explain any slight variations in binding affinity of HMGA1 for UV photoproducts.
It appears, nevertheless, that CPDs do not markedly influence HMGA1 binding to AT-rich DNA.
UV photofootprints suggest that HMGA1 binding induces a structural change in the T 18 -tract of PRRII DNA. Long stretches of dT residues impart an altered structure to DNA (so called B'-DNA) as a result of increased rigidity of the DNA caused by enhanced purine-purine stacking interactions, high propeller twist of bases, additional (bifurcated) hydrogen bonds and a narrow minor groove (48, 49) . By adopting this unusual DNA conformation, a long stretch of poly(dT) (e.g., T 15 ATAT 16 and T 34 ) tends to be excluded from nucleosome cores (50) , and thus, the DNA structure may allow transcription factors to access such sequences in a nucleosome-free region. In contrast, short stretches of T-tract DNA can be accommodated in nucleosomes (34, 50) and nucleosome folding can modulate the unusual T-tract structure (51) . The rigid DNA structure inside a T-tract may increase the transition energy required for formation of CPDs. Thus, as discussed by Lyamichev (42) , because of this increased rigidity the CPD yield at the 3' end of a T-tract is expected to be higher than in its interior.
Consistent with this suggestion, we observe that UV irradiation of the T 18 sequence in naked PRRII fragments produces a CPD distribution with a maximum near its 3' end ( Figures 5B  and 5C ), indicating that a structure typical of long Ttracts exists in the T 18 region of naked PRRII fragments.
In contrast to the CPD pattern of naked PRRII DNA, the UV photofootprint of HMGA1-DNA complexes shows an overall increase in CPD yields, most strikingly at three different positions in the T 18 sequence ( Figure 5C ). These sites most likely correspond to the three AT-hook binding sites of the HMGA1 protein on this stretch of DNA (33) . Assuming that the orientation of HMGA1 on free DNA is similar to its binding on nucleosome core particles (34), the high CPD yields at ~ 3 -7 nts from the 3' end of the T 18 -tract are likely produced by the binding of AT-hook 3, while the other peaks (at positions ~ 10 -13 nts and at ~16 nt from the 3' end) are probably due to binding of AThooks 2 and 1, respectively (33) .
Although the molecular structure of the full-length HMGA1-DNA complex is unknown, the CPD distribution of the complex implies that HMGA1 changes the rigid B'-DNA structure upon binding.
The repair results shown in Figure 6 demonstrate that HMGA1 binding inhibits repair of CPDs in vitro. One explanation is that, as observed with other protein-DNA complexes, HMGA1 molecules physically block access of NER proteins to DNA at HMGA1 binding sequences. To shield DNA damage, HMGA1 is required to bind tightly to its cognate DNA containing CPDs. Related to the binding affinity, a dissociation constant of 2 to 3 nM was obtained for HMGA1 and the 5'-untranslated region of the bovine interleukin-2 cDNA (52), and a dissociation constant of 0.8 nM was obtained for truncated HMGA1, consisting of AT hooks 2 and 3, and a 31 bp fragment of the PRDII region of the IFN-β promoter (47) . In addition, the results in Figure 4B imply that UV photoproducts do not markedly change the binding affinity of HMGA1 in the complex. Thus, it seems likely that HMGA1 binds the T 18 -tract containing CPDs with a high binding affinity and shields CPDs from the NER machinery. (Figure 6A and B) .
Additionally, the repair data in Figure 6 indicate that, in spite of slow repair, CPDs in the T 18 -tract of the complex are almost completely removed after 2 to 3 hr in the extract. From the notion that a repair time course for a protein-DNA complex reflects the 'offrate' of the complex (53; Kwon, Y. H. and Smerdon, M. J. DNA Repair in a Protein-DNA Complex: Searching for the Key to Get In. Mutat. Res., in press, available online 5-20-05) , HMGA1 proteins may have a slow dissociation rate from the T 18 -tract. This allows, however, NER proteins access to the lesions, but at a reduced rate compared to that of free DNA. In addition, moderate inhibition of repair was observed in regions outside the strong HMGA1 binding sites ( Figure 6A) .
It is possible that low affinity interactions may occur between those sequences and HMGA1, or rather, protein-protein interactions of individual HMGA1 molecules might lead to assembly of a higher order complex (25) . Additionally, protein-protein interactions of HMGA1 could inhibit sequential changes in DNA architecture that are required for intermediate stages of NER.
The results from the in vitro experiments strongly suggest that the observed inhibition of global genomic repair of UV-irradiated intact cells that are over-expressing HMGA1 (Figure 3 ) is likely due, at least in part, to direct binding of these proteins to CPD lesions, inhibiting access of repair-associated proteins. Nevertheless, we cannot exclude the possibility that HMGA1 proteins in these cells may be directly interacting with repair factors thereby sequestering them from repair activities. Likewise, the HMGA1 proteins may negatively regulate transcription of certain genes which code for repair factors, also resulting in decreased repair efficiency (32) . Consistent with this latter possibility, northern blot and quantitative PCR analyses indicates that the XPA gene is down-regulated in transgenic MCF7 cells over-expressing HMGA1 proteins, compared to their non-expressing counterparts (unpublished results). This provides some clarity to an apparent discrepancy between in vitro repair assays (Figure 6) , in which all CPDs were eventually removed from HMGA1-DNA complexes, and repair analyses performed in living cells (Figures 3A & C) . In the latter case, cells that are over-expressing HMGA1 exhibit not only a delay in the onset of repair following UV exposure, but also lag behind control, non-overexpressing cells in their extent of DNA repair even 24 hours after irradiation.
HMGA1 has been proposed to be involved in alterations of chromatin structure that may occur by competing with linker histones (H1) for DNA binding and/or by helping to recruit chromatin remodeling complexes (25) . It is therefore possible that HMGA1 can modulate DNA repair in a different fashion than observed here when DNA damage is folded into a nucleosome. Indeed, a recent report by Birger et al. (16) shows that the HMGN1 protein (a member of a separate HMG family) actually increases NER in intact cells, possibly by facilitating access to chromatin DNA. Like HMGN1, HMGA1 also has a high affinity for nucleosome core particles (26) and, upon binding, induces localized changes in chromatin structure that could facilitate gene transcription (54). However, the types of alterations in chromatin structure induced by these structurally distinct HMG proteins may be quite different from each other since they have opposite effects on the efficiency of NER in chromatin of living cells. Thus, our finding that HMGA1 inhibits NER and modulates CPD yields needs to be investigated further using nucleosomes and chromatin as binding substrates of HMGA1. Moreover, HMGA1 is subject to extensive posttranslational modification during apoptosis and the cell cycle (55,56). Since modification of AT-hook domains is known to decrease binding affinity for its cognate DNA binding sites (52), it will be important to examine how modification of HMGA1 proteins modulates DNA repair.
Finally, greatly increased levels of expression of both HMGA1 transcripts (57) and proteins (25) are consistently observed features of many naturally occurring cancers (including breast, prostate, lung, thyroid, cervical, colorectal and pancreatic cancers and leukemias), with increasing HMGA1 levels directly correlating with increasing malignancy and metastatic potential of the tumors (58). Additionally, chimeric proteins with AT-hook domains are produced as a result of chromosomal rearrangements in a variety of benign mesenchymal tumors including lipomas, leiomyomas, and endometrial polyps as well as others (59). The results of the present study suggest that the elevated levels of HMGA1 found in cancer cells may significantly increase their likelihood of accumulating genomic damage over time. Thus, the association of DNA repair and HMGA1 could be important for the acquisition of genetic and chromosomal instabilities that are frequently associated with tumor progression and increased metastatic potential of cancers. In this connection, it has recently been suggested that elevated levels of endogenous HMGA1 proteins are closely associated with the appearance of chromosomal rearrangements in prostate cancer cells (61).
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